Icon Writers
Icon Group today (27 February 2026) announced the transition of its China operations to local ownership under a consortium of senior management in the region.
Icon Group today (27 February 2026) announced the transition of its China operations to local ownership under a consortium of senior management in the region.
For the past 12 months, several parties have been connecting with the Group regarding potential acquisition opportunities, including the consortium of Icon China’s senior management.
“The transition of ownership to this consortium is an outstanding result for both our local teams and the patients they care for,” said Mark Middleton OAM, Icon Group CEO.
“Many members of this group have been with Icon China since its early days, playing a pivotal role in improving outcomes for communities that previously had limited or no access to world-class cancer treatment. Knowing these leaders - who understand the needs of the region and carry deep commitment to Icon’s values - will continue to advance our cancer care legacy is both reassuring and humbling.
“As the first Australian and only healthcare organisation to deliver cancer care in China, Icon Group is incredibly proud of the impact we have made since launching operations.
“Despite the challenges of COVID, our team were true pioneers successfully opening five cancer centres, building a highly skilled workforce trained by our Australian clinical leaders and introducing advanced technologies to help address the region’s growing cancer burden."
"We’ve established a model of care that now provides a strong foundation for the new owners as they continue driving long-term improvements in cancer treatment and outcomes.”
This move further enhances Icon Group’s capacity to continue delivering and expanding leading healthcare services across Australia, New Zealand, Europe, and the ASEAN region.
The transition is expected to complete mid-2026.